Pancreatic cancer is one of the most serious and deadly forms of cancer. It is often called a “silent” disease because it usually does not cause clear symptoms in its early stages.
By the time it is found, the cancer has often already spread to other parts of the body, making it very difficult to treat. Because of this, early detection is one of the biggest challenges doctors face.
Now, scientists at Oregon Health & Science University have developed a new blood test that could help change this situation. The test, called PAC-MANN, may allow doctors to detect pancreatic cancer much earlier than before. This could give patients more treatment options and improve their chances of survival.
PAC-MANN is a new type of test that uses a very small amount of blood to look for signs of cancer. It focuses on special proteins in the body called proteases. These proteins play a role in many normal body processes, but they become more active when cancer is present.
The test is designed to detect changes in these proteins, especially in a common and aggressive type of pancreatic cancer called pancreatic ductal adenocarcinoma, or PDAC. By measuring how active these proteases are, the test can identify whether cancer may be present.
Currently, doctors often use a blood test called CA 19-9 to monitor pancreatic cancer. However, this test has limits. It is not very effective at detecting cancer in its early stages. Often, it only shows clear results after the disease has already progressed. This means patients may miss the best chance for early treatment.
The PAC-MANN test was created to improve on this. It is designed to be faster, simpler, and more accurate in finding early signs of cancer.
In a study, researchers tested blood samples from 350 people. Some of the participants had pancreatic cancer, some were considered at high risk, and others were healthy. The results were very promising. The test was able to correctly identify cancer with about 98 percent accuracy.
When the new test was combined with the traditional CA 19-9 test, it performed even better. Together, they were able to detect early-stage pancreatic cancer with about 85 percent accuracy. This is important because early detection can greatly improve treatment success.
Another useful feature of the test is its ability to track how well treatment is working. After patients had surgery to remove cancer, the levels of protease activity in their blood went down. This suggests that the test could help doctors monitor recovery and adjust treatments if needed.
One of the most exciting parts of this discovery is how simple and affordable the test is. It only requires a tiny drop of blood, about 8 microliters, which is much less than most standard tests. The results can be ready in less than an hour, and each test costs less than one cent. This makes it possible to use the test widely, even in areas with limited medical resources.
The researchers wanted to create a tool that could be used not only in large hospitals but also in smaller clinics and rural areas. A low-cost and easy-to-use test like this could make a big difference in global health, especially in places where access to advanced medical equipment is limited.
Although the results are very encouraging, the scientists say more research is needed. They plan to carry out larger studies, especially in people who are at higher risk of developing pancreatic cancer. These include individuals with a family history of the disease or certain medical conditions.
If future studies confirm these findings, PAC-MANN could become an important tool in the early detection of pancreatic cancer. It may also help doctors follow patients more closely during and after treatment.
This research offers new hope in the fight against one of the most challenging cancers. It shows how new ideas and simple tools can lead to major advances in medicine.
If you care about cancer, please read studies that artificial sweeteners are linked to higher cancer risk, and how drinking milk affects risks of heart disease and cancer.
For more health information, please see recent studies about the best time to take vitamins to prevent heart disease, and results showing vitamin D supplements strongly reduces cancer death.
The study was published in the scientific journal Science Translational Medicine.
Copyright © 2026 Knowridge Science Report. All rights reserved.
